Sleep and Inflammatory Resolution Pathway

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 6, 2018

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions

Inflammatory ResponseInflammationSleepSleep Restriction

Interventions

DRUG

Aspirin

81mg aspirin pill daily at bedtime over a 25 day period

DRUG

Placebo

81mg non-active pill that looks like aspirin

Trial Locations (1)

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors

lead

Beth Israel Deaconess Medical Center

OTHER